Rabbit antiserum raised against a normal-derived monoclonal anti-DNA antibody KIM 4.63 (IgM lambda) 
Introduction
Anti-DNA autoantibodies are characteristic of human systemic lupus erythematosus (SLE) and its murine equivalent. Genes encoding anti-DNA antibodies, however, are not re-stricted to this autoimmune disease and are part of the normal B cell repertoire. The generation of anti-DNA antibody responses was demonstrated in cultures of peripheral blood lymphocytes (1, 2) , normal tonsillar lymphocytes (1) , in a human:human hybridoma system derived from lymphoid cells of normal individuals (3) (4) (5) and in nonautoimmune strains of mice (6, 7) . These normal-derived anti-DNA antibodies are qualitatively identical to those produced in SLE in that they exhibit an identical spectrum of antigen binding characteristics in which not only nucleic acid antigens are included but also human IgG, cardiolipin, and vimentin (1, (8) (9) (10) .
The anti-DNA antibodies of SLE express cross-reactive idiotypes as determined using monoclonal and polyclonal antiidiotypic reagents (11) (12) (13) . SLE anti-DNA antibody idiotypes were detected in the sera of normal strains of mice (14) , in culture supernatants of splenic cells obtained from normal mice (15) , in sera from healthy members of SLE families (16) , and on myeloma immunoglobulin recognizing bacterial antigen (17) . These findings indicate a common derivative in SLE and normals of DNA and non-DNA-reactive antibodies from a single or a limited number of related genes. In the murine system, the usage of common genetic elements for MRL/lpr/ lpr anti-DNA antibody and for antibodies to exogenous antigens has been recently demonstrated by nucleotide sequence data comparison (18) .
In this paper we provide additional evidence for the possible recruitment in SLE and normals of the same or closely related genes in DNA and non-DNA antibody responses in which major cross-reactive idiotype of normal-derived monoclonal anti-DNA antibody frequently occurs.
Methods
Characteristics of monoclonal anti-DNA antibody 4.6.3. KIM 4.6.3 monoclonal anti-DNA antibody was derived from a hybridoma obtained after the fusion of tonsillar lymphoid cells from a normal individual with the lymphoblastoid cell line GM 4672 (Human Genetic Mutant Cell Repository, Camden, NJ) as previously described (3) . KIM 4.6.3 monoclonal anti-DNA antibody was of IgMA isotype and it displayed reactivity with various nucleic acid antigens including: single stranded DNA (ssDNA),' native DNA (DNA), synthetic double stranded polymers: polydeoxyguanylate-polydeoxycytidylate (poly dG * poly dC) and polydeoxyadenylate-thymidylate sodium salt (poly [dA-dT]), a low molecular weight DNA (-150 base pairs, 80% 1. Abbreviations used in this paper: CFA, complete Freund's adjuvant; ID, idiotype; IFA, incomplete Freund's adjuvant; poly (dA-dT), polydeoxyadenylate-thymidylate sodium salt; poly dG-poly dC, polydeoxyguanylate-polydeoxycytidylate; NRS, normal rabbit serum; RT, room temperature; ssDNA, single-stranded DNA; S/N, supernatant; WB, washing buffer. double stranded [19] ), and ribonucleic acid (RNA). This KIM 4.6.3 antibody bound weakly to cardiolipin.
Purification of KIM 4.6.3 anti-DNA antibody. KIM 4.6.3 anti-DNA antibody was chromatographically purified on silica (Boehringer Mannheim GmbH, Mannheim, W. Germany) coupled rabbit antihuman IgM (As chain specific) (DAKO, Copenhagen, Denmark). The coupling of rabbit anti-human IgM to silica was performed according to the instructions from Boehringer Mannheim attached with the silica reagent. Approximately 300 ml of the KIM 4.6.3 hybridoma supernatant was passed at room temperature (RT) through the silica-rabbit anti-human IgM packed column (15 cm height 1 cm diameter). The column was then extensively washed with 3% NaCl until absorbance at 280 nm was < 0.005 OD units. The bound antibody was eluted with 2 mol/liter sodium thiocyanate (J. T. Baker Chemical Co., Phillipsburg, NJ). l-ml fractions were collected and those which contained protein (determined spectrophotometrically at 280 nm) were pooled. The eluted antibody solution (20-25 ml) was dialyzed for 48-72 h at 4VC against six changes of PBS, pH 7.4 (Gibco Laboratories, Grand Island, NY). This dialyzed antibody solution was subsequently concentrated by Amicon Filtration on an XM 300 membrane (Amicon Corp., Lexington, MA) and underwent further final dialysis at 4VC with three changes ofPBS pH 7.4 (Gibco Laboratories) during 48 h. This preparation yielded 5 ml of IgM antibody solution (120 Mg/ml), which had reactivity with ssDNA and which lacked detectable human IgG or rabbit Ig when tested by ELISA (3).
Production ofanti-4. In a different inhibition assay (Fig. 3) , the binding of anti-4.6.3 ID to KIM 4.6.3 antibody was abolished or decreased in the presence of affinity purified homologous antibody. The homologous hybridoma supernatant used at an IgM concentration equivalent to the purified KIM 4.6.3 antibody showed a similar inhibitory effect. This suggests that during purification, the variable portion of KIM 4.6.3 antibody was not altered. The inhibition of anti-4.6.3 ID binding to KIM 4.6.3 AB was also observed with three of eight anti-DNA hybridoma S/N tested: KIM 4.5 (IgMA), KIM 4.3 (IgMX) and KIM 9.1 (IgMK) (Fig. 3) but not with KIM 1 1.4 (IgMA) (Fig. 3) (Fig. 3) as well as normal human IgM, IgG, or IgGK containing S/N from GM 4672 cell line (used undiluted) had no inhibitory effect. 
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The above results imply that anti-4.6.3 ID recognizes a public or cross-reactive idiotype which in addition to KIM 4.6.3 is expressed by some other monoclonal anti-DNA antibodies (KIM 4.5, KIM 4.3, KIM 9.1).
Reactivity ofanti-4.6.3 ID with DNA and non-DNA binding monoclonal antibodies. The qualitative assessment of 4.6.3 expression was performed by directly testing a large panel (102) of undiluted hybridoma supernatants for binding to anti-4.6.3 ID in direct ELISA. 30 of these supernatants contained IgM anti-DNA and/or anticardiolipin binding antibodies, while the remaining 72 supernatants contained IgM antibodies without DNA and/or cardiolipin reactivity. These tested antibodies were derived from the fusions of four different unrelated normal individuals (KIM) (Fig. 4) , KIR, KEL, CAR, and ROB (Table I ). In supernatants from KIM hybridomas, 4.6.3 ID was detected in 7/22 (32%) anti-DNA and/or anticardiolipin antibodies in addition to KIM 4.6.3 S/N and KIM 4.6.3 affinity purified antibody (KIM P 4.6.3) (Fig. 4 a) . In KIM hybridoma supernatants lacking reactivity with nucleic acid and/or cardiolipin, 7/22 (32%) IgM antibodies were 4.6.3 ID positive (Fig. 4 b) .
The inability to detect 4.6.3 ID did not appear to be a function of low IgM expression in 4.6.3 ID negative supernatants since some of them showed equal or higher IgM concentrations (e.g., KIM 7.2, 8 ,ug/ml IgM; KIM 11.4, 2.1 ,ug/ml IgM) than the 4.6.3 ID positive supernatants, (e.g., KIM The 4.6.3 ID was expressed also on hybridoma antibodies obtained from the fusions of different unrelated normal individuals KIR, CAR, and ROB at a frequency similar to the frequency among KIM hybridoma antibodies (23-31%). A higher frequency (50%) of 4.6.3 ID expression was also detected in hybridoma supernatant from the KEL fusion (Table  I ). In these hybridoma supernatants 4.6.3 ID expression was also not restricted to antibodies with nucleic acid reactivities. Thus in all fusions, the overall frequency ofexpression of4.6.3 ID was 33% among DNA binding and 32% among non-DNA binding monoclonal antibodies.
The expression of4.6.3 ID in SLE and normal human sera. Human sera from 50 randomly chosen normal individuals and from 40 SLE patients were tested at different dilutions (l0-2-2 X 10-") for the presence of 4.6.3 ID by the ELISA method using anti-4.6.3 ID.
The 4.6.3 ID was expressed in 43-90% of the SLE and in 0-24% of normal sera depending on the dilution of serum tested (Fig. 5) (Fig. 7) or anti-DNA antibodies (Fig. 8 ) in sera of these SLE patients.
Discussion
We have shown in this study that the 4.6.3 idiotype expressed on a normal-derived monoclonal anti-DNA antibody (KIM (1 1, 15, 26-29 ) who studied genetic elements encoding SLE anti-DNA antibodies using antiidiotype probes raised against idiotypes on nucleic acid reactive lupus-derived antibodies. Our experimental reciprocal approach examining the abnormal expression of a normal-derived ID complements theirs and the findings among these groups are thus similar. For example the cross-reactive idiotype H-130 expressed by anti-DNA antibody from MRL/lpr/lpr autoimmune strain of mice was described by Andrzejewski et al. (27) . In this strain of mice H-130 was represented in about 50% of the serum immunoglobulins and less than half of the H-130 positive Ig had antinucleic acid reactivity. Different strains of autoimmune mice shared H-130 ID (28) . A correlation of this ID expression and the severity of the disease in MRL/lpr/lpr mice was noted. Furthermore, lipopolysaccharide (LPS) stimulated the production of anti-DNA antibodies bearing H-130 in normal spleen lymphocyte cultures (15) .
In man, a public idiotypic marker termed 16/6 derived from an SLE monoclonal anti-DNA antibody was shared with monoclonal anti-DNA antibodies from different SLE patients (29) with serum immunoglobulins from more than half of the SLE patients with active disease, and with 4% of normal human sera (30). Some pathogenic relevance was assigned to 16/6 ID since its presence could be demonstrated in skin and the renal glomerulus from SLE patients (23, 24). Peripheral blood lymphocytes from normal individuals produced Ig, which expressed the 16/6 ID in vitro after stimulation with pokeweed mitogen (31) , with bacteria (32), or with a-interferon (33) . Some of the 16/6 ID-positive antibodies in the cultures with a-interferon were DNA reactive. We have also shown that the immunoglobulins from normal peripheral blood lymphocytes in short-term pokeweed mitogen stimulated cultures expressed ID 4.6.3 but did not bind DNA (21) . Another public idiotype, 3I, was described for human anti-DNA antibodies (1 1). It was identified by a mouse monoclonal antibody obtained from spleen cells of a mouse immunized with affinity-purified human IgG SLE serum anti-DNA antibodies. This 31 idiotypic marker was expressed at high levels in 85% of the sera from SLE patients. The sera from unaffected SLE relatives also contained antibodies with 3I ID but without DNA binding properties. The relationship among these different idiotypes is under study.
A uniform picture emerges from these findings. The anti-DNA antibodies of SLE and normal individuals are idiotypically related to one another and are also idiotypically related to non-DNA binding antibodies. The molecular analyses which have already been initiated support the idea that these antinucleic acid autoantibodies are encoded by germ line genes (34, 35) . In our laboratory, we have recently completed cloning and nucleotide sequence analyses of VH and VL genes encoding KIM 4.6.3 anti-DNA antibody and found that 4.6.3 ID is also of germ line gene origin (manuscript in preparation). Experiments are underway to precisely determine whether the variable light or heavy chain genes (or their segments) correlate with 4.6.3 ID expression amongst the various DNA and non-DNA antibodies studied here.
